Shanghai Novamab Biopharmaceuticals Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Novamab Biopharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma (NCT07589439) | Shanghai Novamab Biopharmaceuticals Co., Ltd. | 2025-09-30 |
Track Shanghai Novamab Biopharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.